These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [The surgical results in malignant bladder tumors using the Scalpel-1 carbon-dioxide laser]. Dmitriev BV; Nikol'skiĭ AD; Latyshev MM; Zolin VP; Sanevich RA Urol Nefrol (Mosk); 1997; (1):25-8. PubMed ID: 9123661 [TBL] [Abstract][Full Text] [Related]
28. External validation of extranodal extension and lymph node density as predictors of survival in node-positive bladder cancer after radical cystectomy. Masson-Lecomte A; Vordos D; Hoznek A; Yiou R; Allory Y; Abbou CC; de la Taille A; Salomon L Ann Surg Oncol; 2013 Apr; 20(4):1389-94. PubMed ID: 23208127 [TBL] [Abstract][Full Text] [Related]
29. The role of MR imaging in carcinoma of the urinary bladder. Barentsz JO; Ruijs SH; Strijk SP AJR Am J Roentgenol; 1993 May; 160(5):937-47. PubMed ID: 8470608 [TBL] [Abstract][Full Text] [Related]
30. Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy. Palmieri F; Brunocilla E; Bertaccini A; Guidi M; Pernetti R; Morselli-Labate AM; Martorana G Anticancer Res; 2010 Jul; 30(7):2973-6. PubMed ID: 20683041 [TBL] [Abstract][Full Text] [Related]
33. Multiple adverse histological features increase the odds of under staging T1 bladder cancer. Weizer AZ; Wasco MJ; Wang R; Daignault S; Lee CT; Shah RB J Urol; 2009 Jul; 182(1):59-65; discussion 65. PubMed ID: 19447443 [TBL] [Abstract][Full Text] [Related]
34. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients. Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867 [TBL] [Abstract][Full Text] [Related]
35. [Morphology of bladder cancer with reference to cystectomy specimen]. Presse S; Savvas V; Kuntz RM Pathologe; 1993 Sep; 14(5):253-9. PubMed ID: 8415434 [No Abstract] [Full Text] [Related]
36. [Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation]. Venz S; Ilg J; Ebert T; Hierholzer J; Friedrichs R; Hosten N; Felix R Urologe A; 1996 Jul; 35(4):297-304. PubMed ID: 8928358 [TBL] [Abstract][Full Text] [Related]
37. [The clinical value of preoperative staging of bladder and prostatic cancers with nuclear magnetic resonance and computerized tomography]. Beer M; Schmidt H; Riedl R Urologe A; 1989 Mar; 28(2):65-9. PubMed ID: 2718295 [TBL] [Abstract][Full Text] [Related]
38. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214 [TBL] [Abstract][Full Text] [Related]
39. Reliability of CT in preoperative evaluation of bladder carcinoma. Nurmi M; Katevuo K; Puntala P Scand J Urol Nephrol; 1988; 22(2):125-8. PubMed ID: 3206216 [TBL] [Abstract][Full Text] [Related]
40. [A comparison between intraurethral echography, computed tomography and magnetic resonance in the staging of bladder tumors]. Gualdi GF; Volpe A; Polettini E; Ceroni AM Clin Ter; 1992 Nov; 141(11):393-7. PubMed ID: 1493663 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]